Clinical Liver Disease

Treatment options for anti-HCV treatment-experienced patients, Peter Ferenci - Article Reading

Informações:

Sinopsis

Treatment failure with pegylated interferon (PEG-IFN)/ribavirin (RBV) dual therapy can be due to either the persistence of hepatitis C virus (HCV) RNA throughout treatment (nonresponse) or the reappearance of the virus after the end of treatment.